Table 3.
Changes of patients’ indicators in A subgroups before and after treatment of 7 days.
| Before | After treatment of 7 days | |||||
| Variable | Group A1 | Group A2 | P | Group A1 | Group A2 | P |
| IAP (mm Hg) | 25.20 ± 2.96 | 26.14 ± 2.54 | .312† | 15.00 ± 2.93 | 12.43 ± 3.75 | .023∗ |
| OI (mm Hg) | 169.8 ± 40.5 | 159.8 ± 38.2 | .451† | 213.0 ± 48.5 | 253.1 ± 53.7 | .019∗ |
| RR (beats/min) | 30.4 ± 3.2 | 32.1 ± 4.6 | .279∗ | 26.0 ± 1.9 | 24.0 ± 3.4 | .045† |
| HR (beats/min) | 129.3 ± 7.1 | 132.6 ± 10.0 | .274† | 108.7 ± 12.1 | 106.1 ± 13.1 | .543† |
| MAP (mm Hg) | 67.2 ± 9.3 | 68.8 ± 9.1 | .607† | 72.3 ± 6.3 | 77.4 ± 7.8 | .044† |
| ALT (U/L) | 72.27 ± 23.17 | 84.86 ± 28.49 | .487† | 64.67 ± 13.85 | 73.76 ± 20.12 | .140† |
| TG (mmol/L) | 17.59 ± 4.86 | 15.09 ± 4.25 | .110† | 10.22 ± 1.98 | 8.23 ± 2.37 | .012† |
| CR (mmol/L) | 225.3 ± 62.8 | 244.7 ± 72.0 | .407† | 141.6 ± 39.4 | 117.6 ± 29.0 | .011∗ |
| WBC (109/L) | 12.04 ± 3.54 | 13.53 ± 3.48 | .215† | 10.96 ± 2.21 | 9.28 ± 2.33 | .037† |
| PCT (ng/mL) | 2.15 ± 1.27 | 2.59 ± 1.64 | .400† | 1.28 ± 0.68 | 0.83 ± 0.56 | .049∗ |
| IL-6 (ng/L) | 117.97 ± 30.30 | 122.69 ± 37.96 | .751∗ | 66.08 ± 22.54 | 46.85 ± 26.20 | .016∗ |
| CRP (mg/L) | 240.7 ± 76.6 | 255.6 ± 97.7 | .615† | 144.3 ± 55.0 | 93.9 ± 50.4 | .007† |
| APACHE II | 14.27 ± 2.91 | 15.57 ± 2.73 | .294∗ | 9.80 ± 1.78 | 8.29 ± 1.55 | .016∗ |
ALT = alanine transaminase, APACHE II = acute physiology and chronic health evaluation score II, CR = creatine, CRP = C-reactive protein, HR = heart rate, IAP = intra-abdominal pressure, IL-6 = interleukin-6, MAP = mean arterial pressure, OI = oxygenation index, PCT = procalcitonin, RR = respiratory rate, TG = triglyceride, WBC = white blood cell.
∗
Mann–Whitney test.
†
Independent samples t test.